Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Goodwill & Intangibles (2018 - 2026)

Profound Medical has reported Goodwill & Intangibles over the past 8 years, most recently at $1.3 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles rose 388.51% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 388.51%, while the annual FY2025 figure was $1.3 million, 388.51% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $1.3 million at Profound Medical, up from $123000.0 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $3.9 billion in Q1 2022 and troughed at $123000.0 in Q3 2025.
  • A 5-year average of $240.6 million and a median of $1.2 million in 2025 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: surged 117391.47% in 2021 and later plummeted 99.93% in 2024.
  • Year by year, Goodwill & Intangibles stood at $4.1 million in 2021, then crashed by 83.51% to $680000.0 in 2022, then decreased by 27.94% to $490000.0 in 2023, then plummeted by 46.73% to $261000.0 in 2024, then skyrocketed by 388.51% to $1.3 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for PROF at $1.3 million in Q4 2025, $123000.0 in Q3 2025, and $1.2 million in Q2 2025.